Latest Altitude Crest Partners Inc. Stock Portfolio
Altitude Crest Partners Inc. Performance:
2024 Q1: 4.09%YTD: 4.09%
Performance for 2024 Q1 is 4.09%, and YTD is 4.09%.
About Altitude Crest Partners Inc. and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Altitude Crest Partners Inc. reported an equity portfolio of $233.6 Millions as of 31 Mar, 2024.
The top stock holdings of Altitude Crest Partners Inc. are LEGN, DHR, BBIO. The fund has invested 15.7% of it's portfolio in LEGEND BIOTECH CORP and 11.6% of portfolio in DANAHER CORPORATION.
The fund managers got completely rid off ARGENX SE (ARGX), BIOMARIN PHARMACEUTICAL INC (BMRN) and EXACT SCIENCES CORP (EXAS) stocks. They significantly reduced their stock positions in ROIVANT SCIENCES LTD (ROIV), BRIDGEBIO PHARMA INC (BBIO) and KINIKSA PHARMACEUTICALS LTD (KNSA). Altitude Crest Partners Inc. opened new stock positions in STEVANATO GROUP S P A (STVN), THERMO FISHER SCIENTIFIC INC (TMO) and ARRIVENT BIOPHARMA INC. The fund showed a lot of confidence in some stocks as they added substantially to APELLIS PHARMACEUTICALS INC (APLS) and LEGEND BIOTECH CORP (LEGN).
The top stock holdings of Altitude Crest Partners Inc. are LEGN, DHR, BBIO. The fund has invested 15.7% of it's portfolio in LEGEND BIOTECH CORP and 11.6% of portfolio in DANAHER CORPORATION.
The fund managers got completely rid off ARGENX SE (ARGX), BIOMARIN PHARMACEUTICAL INC (BMRN) and EXACT SCIENCES CORP (EXAS) stocks. They significantly reduced their stock positions in ROIVANT SCIENCES LTD (ROIV), BRIDGEBIO PHARMA INC (BBIO) and KINIKSA PHARMACEUTICALS LTD (KNSA). Altitude Crest Partners Inc. opened new stock positions in STEVANATO GROUP S P A (STVN), THERMO FISHER SCIENTIFIC INC (TMO) and ARRIVENT BIOPHARMA INC. The fund showed a lot of confidence in some stocks as they added substantially to APELLIS PHARMACEUTICALS INC (APLS) and LEGEND BIOTECH CORP (LEGN).
Altitude Crest Partners Inc. Annual Return Estimates Vs S&P 500
Our best estimate is that Altitude Crest Partners Inc. made a return of 4.09% in the last quarter. In trailing 12 months, it's portfolio return was NA%.
New Buys
| Ticker | $ Bought |
|---|---|
| stevanato group s p a | 17,655,000 |
| thermo fisher scientific inc | 10,694,300 |
| arrivent biopharma inc | 9,922,210 |
| structure therapeutics inc | 8,793,420 |
| janux therapeutics inc | 7,277,740 |
| eli lilly & co | 7,157,230 |
| biohaven ltd | 6,474,200 |
| immunome inc | 6,473,170 |
New stocks bought by Altitude Crest Partners Inc.
Additions
| Ticker | % Inc. |
|---|---|
| apellis pharmaceuticals inc | 88.75 |
| legend biotech corp | 20.47 |
Additions to existing portfolio by Altitude Crest Partners Inc.
Reductions
| Ticker | % Reduced |
|---|---|
| roivant sciences ltd | -43.72 |
| bridgebio pharma inc | -18.89 |
| kiniksa pharmaceuticals ltd | -12.19 |
| danaher corporation | -10.61 |
Altitude Crest Partners Inc. reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| biomarin pharmaceutical inc | -10,995,900 |
| exact sciences corp | -7,333,640 |
| ambrx biopharma inc | -613,744 |
| argenx se | -11,222,700 |
Altitude Crest Partners Inc. got rid off the above stocks
Sector Distribution
Altitude Crest Partners Inc. has about 61.3% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 61.3 |
| Others | 38.7 |
Market Cap. Distribution
Altitude Crest Partners Inc. has about 19.2% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 38.7 |
| MID-CAP | 30.8 |
| LARGE-CAP | 11.6 |
| SMALL-CAP | 10 |
| MEGA-CAP | 7.6 |
| NANO-CAP | 1.2 |
Stocks belong to which Index?
About 44.1% of the stocks held by Altitude Crest Partners Inc. either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 56 |
| RUSSELL 2000 | 24.8 |
| S&P 500 | 19.3 |
Altitude Crest Partners Inc. Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Altitude Crest Partners Inc.
Altitude Crest Partners Inc. has 30 stocks in it's portfolio. About 69.3% of the portfolio is in top 10 stocks. BBIO proved to be the most loss making stock for the portfolio. JANX was the most profitable stock for Altitude Crest Partners Inc. last quarter.
Last Reported on: 14 May, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| AGIO | agios pharmaceuticals inc | 1.42 | 113,100 | 3,307,040 | new | |||
| ALGS | aligos therapeutics inc | 1.19 | 2,844,680 | 2,787,790 | unchanged | 0.00 | ||
| ALNY | alnylam pharmaceuticals inc | 0.01 | 200 | 29,890 | new | |||
| AMAM | ambrx biopharma inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| APLS | apellis pharmaceuticals inc | 7.23 | 287,277 | 16,886,100 | added | 88.75 | ||
| APLT | applied therapeutics inc | 0.76 | 259,700 | 1,765,960 | new | |||
| ARGX | argenx se | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BBIO | bridgebio pharma inc | 8.10 | 612,060 | 18,924,900 | reduced | -18.89 | ||
| BMRN | biomarin pharmaceutical inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CRBP | corbus pharmaceuticals hldgs | 1.74 | 103,703 | 4,069,310 | new | |||
| DAWN | day one biopharmaceuticals i | 1.38 | 195,497 | 3,229,610 | new | |||
| DHR | danaher corporation | 11.62 | 108,700 | 27,144,600 | reduced | -10.61 | ||
| DNLI | denali therapeutics inc | 1.84 | 209,613 | 4,301,260 | new | |||
| EXAS | exact sciences corp | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| GERN | geron corp | 2.16 | 1,531,400 | 5,053,620 | new | |||
| ICLR | icon plc | 2.13 | 14,800 | 4,972,060 | new | |||
| IMNM | immunome inc | 2.77 | 262,284 | 6,473,170 | new | |||
| JANX | janux therapeutics inc | 3.12 | 193,300 | 7,277,740 | new | |||
| KNSA | kiniksa pharmaceuticals ltd | 3.38 | 400,441 | 7,900,700 | reduced | -12.19 | ||
| LEGN | legend biotech corp | 15.67 | 652,732 | 36,611,700 | added | 20.47 | ||